GENEVA, Aug. 11 -- VIDAC PHARMA LTD. (Openheimer 77670107 Rehovot) filed a patent application (PCT/IL2025/050092) for "SYNERGISTIC THERAPIES FOR TREATING CANCER" on Jan 26, 2025. With publication no. WO/2025/163633, the details related to the patent application was published on Aug 07, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HERZBERG, Max (Hagefen 427683400 Sitrya), SAGIV, Yuval (12 Smadar Street7041810 Gedera)
Abstract:
The present invention relates combination therapies for treating cancer, said therapies comprising a piperazine derivative and a chemotherapeutic and/or a targete...